![Gregory Licholai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gregory Licholai
Präsident bei
Elpidera LLC
Profil
Gregory P. Licholai, Gründer von Immunome, Inc., ist derzeit Chief Medical & Innovation Officer bei ICON plc und Präsident von Elpidera LLC. Dr. Licholai ist auch Mitglied des Vorstands von Sollis Therapeutics, Inc. Zuvor war er President & Chief Scientific Officer bei Castle Creek Pharmaceuticals LLC, Vice President-Medical Affairs bei Amicus Therapeutics, Inc. sowie Director-Ventures & Business Associates bei Medtronic Neurological und Director bei Immunome, Inc. Gregory P. Licholai erwarb einen Bachelor-Abschluss am Boston College, einen Doktortitel an der Yale University und einen MBA an der Harvard University.
Aktive Positionen von Gregory Licholai
| Unternehmen | Position | Beginn |
|---|---|---|
Elpidera LLC | Präsident | - |
Ehemalige bekannte Positionen von Gregory Licholai
| Unternehmen | Position | Ende |
|---|---|---|
Castle Creek Biosciences, Inc.
 Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Develops gene therapies for patients with skin and genetic diseases | Präsident | 01.02.2018 |
| AMICUS THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 02.10.2009 |
Medtronic Neurological | Corporate Officer/Principal | 01.11.2002 |
| MODERNA, INC. | Corporate Officer/Principal | - |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | - |
Ausbildung von Gregory Licholai
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
30
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
ICON plc
 ICON plc Miscellaneous Commercial ServicesCommercial Services Provides clinical research and development services | Commercial Services |
Amicus Therapeutics, Inc.
 Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases | Health Technology |
Immunome, Inc.
 Immunome, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which discovers, develops and commercializes antibody therapeutics | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medtronic Neurological | |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale School of Medicine
 Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Elpidera LLC | |
Moderna, Inc.
 Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Develops gene therapies for patients with skin and genetic diseases | Health Technology |
